Tag: Eye / Vision Problems: Misc.
Trials Show Promise for Intravitreal Faricimab in Retinal Disease
Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema
Gap Between Retinal Age, Chronological Age Tied to Mortality
An increase in the gap between retinal age and chronological age, known as the retinal age gap, may increase the risk for mortality
Myopia Progression May Continue in Young Adults Into Late 20s
Myopia incidence from age 20 to 28 years was 14 percent
Risk for Diabetic Retinopathy Up for Children With Type 2 Diabetes
Risk significantly increased for requiring pars plana vitrectomy by 15 years after diagnosis for children with type 2 versus type 1 diabetes
ACR: Risk Factors ID’d for Hydroxychloroquine-Related Retinopathy
Independent risk factors for HCQ retinopathy include higher doses, longer duration of use, chronic kidney disease, and Asian race
USPSTF: Evidence Lacking for Screening Seniors for Visual Acuity
Current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic ≥65s in primary care setting
Survival Up With Tebentafusp in Metastatic Uveal Melanoma
Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions
Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization
Maternal Diabetes Ups Offspring Risk for High Refractive Error
Offspring of mothers with diabetic complications have more pronounced increased risks than those of mothers with diabetes without complications
